# ONAPGO
> **NDA214056** · New Drug Application · Sponsor: MDD US · Approved 2025-02-03
## Drug
- **FDA Application Number:** NDA214056
- **Application type:** New Drug Application
- **Brand name:** ONAPGO
- **Generic name:** APOMORPHINE HYDROCHLORIDE
- **Active ingredients:** APOMORPHINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** MDD US
- **Manufacturer:** MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc
- **First approval:** 2025-02-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214056)
---
*AI Analytics · CC0 1.0*